The 150-Year Human: How Close Are We to Radical Life Extension?

The 150-Year Human: How Close Are We to Radical Life Extension?

What if the first person to live to 150 is already alive? It sounds like science fiction, but researchers are making serious strides in the field of longevity. From cellular reprogramming to gene therapy, the idea of radically extending human lifespan is no longer just a thought experiment. Scientists across the world are exploring ways to slow, stop, or even reverse aspects of ageing.

But how close are we? Could we be on the brink of changing human biology, or is true life extension still beyond reach?

Why Do We Age?

Ageing isn’t a single event, it’s a collection of biological mechanisms that break down over time. Scientists have identified several key drivers of the process, including:

  • Cellular senescence – Old, dysfunctional cells that refuse to die, causing inflammation and damage.
  • Telomere shortening – Protective caps on DNA that wear down, leading to errors in cell division.
  • Mitochondrial decline – The energy factories of our cells weakening over time.
  • Epigenetic drift – Changes in how genes are expressed, affecting how the body functions.

Understanding these mechanisms has led to promising interventions aimed at extending the years spent in good health.

The Breakthroughs That Could Push Lifespan Beyond 100

Cellular Reprogramming and the Yamanaka Factors

In 2006, Japanese scientist Shinya Yamanaka discovered a set of four genes, now called Yamanaka factors, that can rewind cells to a more youthful state. This process, known as cellular reprogramming, has already been used in mice to restore organ function and reverse signs of ageing.

In one study, partially reprogrammed mice lived 30 percent longer than normal. Scientists are now investigating whether this technique could be applied to humans to reset biological age at the cellular level.

Senolytics: The Hunt for "Zombie" Cells

As we age, some cells stop functioning properly but refuse to die. These zombie cells, also known as senescent cells, release toxic signals that damage surrounding tissues, increasing inflammation and accelerating ageing.

Drugs known as senolytics are designed to remove these harmful cells. In animal studies, clearing senescent cells has been shown to:

  • Extend lifespan
  • Reduce frailty
  • Improve brain function
  • Boost heart and lung health

Some experimental senolytics, such as fisetin and quercetin, are already available as supplements, though their long-term effects in humans are still being studied.

Gene Therapy for Longevity

Could we rewrite our DNA to live longer? Scientists are already working on gene-editing technologies such as CRISPR to repair or enhance key genetic pathways linked to ageing.

A startup called Rejuvenate Bio is experimenting with gene therapies that have extended the lifespan of mice by 25 percent. They are now moving towards human trials, hoping to tackle age-related diseases at the genetic level.

Rapamycin and mTOR Inhibitors

The drug rapamycin, originally used for organ transplants, has emerged as one of the most promising anti-ageing compounds. It works by inhibiting mTOR, a key pathway in cellular ageing.

Studies in mice have shown that rapamycin can extend lifespan by up to 60 percent. Some longevity researchers and biohackers are already self-experimenting with low-dose rapamycin to see if it provides similar benefits in humans.

Young Blood and Plasma Dilution

One of the more controversial ideas in longevity science is plasma exchange, the process of replacing old blood plasma with younger plasma or saline.

In experiments with mice, older animals given young blood showed improvements in brain function and muscle strength. While the concept has been sensationalised in the media, researchers are exploring whether removing pro-ageing factors from the bloodstream could have real benefits for humans.

The Challenges Ahead

While these breakthroughs are exciting, radical life extension still faces major hurdles:

  • Safety and ethics – How do we ensure these treatments don’t cause unintended side effects?
  • Access and cost – Will longevity breakthroughs be available to everyone or just the wealthy?
  • Regulation – Governments may be slow to approve therapies that fundamentally alter human lifespan.
  • The unknowns – Many longevity interventions have only been tested in animals. Human trials take time.

Despite these challenges, the field of longevity science is accelerating. Billionaires like Jeff Bezos and Sam Altman are investing heavily in age-reversal biotech, and companies like Altos Labs and Calico are dedicated to solving ageing at the molecular level.

So, Will We See a 150-Year-Old Human?

The first person to live to 150 may already be alive, but whether they will reach that age in good health depends on how quickly science progresses.

What’s clear is that ageing is no longer viewed as an unsolvable problem. Researchers are uncovering new ways to slow and even reverse aspects of ageing, and some of these breakthroughs could become widely available in the next decade.

For now, the best approach to longevity is staying ahead of the science and making lifestyle choices that support a long, healthy life. But in the near future, we may have the tools to radically extend human lifespan, and perhaps even make ageing optional.

SOURCES